| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.0036 | 1 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |